{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:24:22Z","timestamp":1771064662072,"version":"3.50.1"},"reference-count":102,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Single-cell sequencing is a high-throughput technique that enables detection of genomic, transcriptomic, and epigenomic information at the individual cell level, offering significant advantages in detecting cellular heterogeneity, precise cell classification, and identifying rare subpopulations. The technique holds tremendous potential in improving the diagnosis and treatment of pancreatic cancer. Moreover, single-cell sequencing provides unique insights into the mechanisms of pancreatic cancer metastasis and cachexia, paving the way for developing novel preventive strategies. Overall, single-cell sequencing has immense potential in promoting early diagnosis, guiding personalized treatment, and preventing complications of pancreatic cancer. Emerging single-cell sequencing technologies will undoubtedly enhance our understanding of the complex biology of pancreatic cancer and pave the way for new directions in its clinical diagnosis and treatment.<\/jats:p>","DOI":"10.3389\/fmed.2023.1213136","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T09:47:50Z","timestamp":1693475270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Advancement of single-cell sequencing for clinical diagnosis and treatment of pancreatic cancer"],"prefix":"10.3389","volume":"10","author":[{"given":"Ke","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13046-021-01874-1","article-title":"Single-cell RNA sequencing in cancer research","volume":"40","author":"Zhang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/annonc\/mdr561","article-title":"The prognostic and predictive value of serum CA19.9 in pancreatic cancer","volume":"23","author":"Humphris","year":"2012","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1158\/1078-0432.CCR-20-3929","article-title":"Development and multiple validation of the protein multi-marker panel for diagnosis of pancreatic cancer","volume":"27","author":"Kim","year":"2021","journal-title":"Clin Cancer Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e476","DOI":"10.1016\/S1470-2045(13)70172-4","article-title":"Improvement of surgical results for pancreatic cancer","volume":"14","author":"Hartwig","year":"2013","journal-title":"Lancet Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1245\/s10434-011-1900-3","article-title":"Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades","volume":"19","author":"Winter","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S2468-1253(20)30330-7","article-title":"Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial","volume":"6","author":"Kunzmann","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13045-020-00958-3","article-title":"Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma","volume":"13","author":"Qian","year":"2020","journal-title":"J Hematol Oncol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1053\/j.seminoncol.2021.02.008","article-title":"Management problems in patients with pancreatic cancer from a surgeon\u2019s perspective","volume":"48","author":"Klose","year":"2021","journal-title":"Semin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.critrevonc.2015.12.008","article-title":"Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilisation: a systematic review","volume":"99","author":"Tarricone","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.molmed.2018.06.002","article-title":"Exercise training as therapy for cancer-induced cardiac cachexia","volume":"24","author":"Antunes","year":"2018","journal-title":"Trends Mol Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1002\/ijc.34468","article-title":"Tissue-resident CXCR4+ macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression","volume":"152","author":"Liao","year":"2023","journal-title":"Int J Cancer"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1158\/2159-8290.CD-21-1248","article-title":"Single-cell sequencing reveals trajectory of tumor-infiltrating lymphocyte states in pancreatic cancer","volume":"12","author":"Schalck","year":"2022","journal-title":"Cancer Discov"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-021-00271-4","article-title":"Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Discov"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.gpb.2020.02.005","article-title":"Direct comparative analyses of 10\u00d7 genomics chromium and smart-seq 2","volume":"19","author":"Wang","year":"2021","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tibtech.2019.09.002","article-title":"Integration of flow cytometry and single cell sequencing","volume":"38","author":"Andreyev","year":"2020","journal-title":"Trends Biotechnol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.molcel.2018.10.020","article-title":"Comparative analysis of droplet-based ultra-high-throughput single-cell RNA-seq systems","volume":"73","author":"Zhang","year":"2019","journal-title":"Mol Cell"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41581-018-0021-7","article-title":"Single-cell RNA sequencing for the study of development, physiology and disease","volume":"14","author":"Potter","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.trecan.2022.06.005","article-title":"Single cell cancer epigenetics","volume":"8","author":"Casado-Pelaez","year":"2022","journal-title":"Trends Cancer"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"648917","DOI":"10.3389\/fimmu.2021.648917","article-title":"Deciphering the prognostic implications of the components and signatures in the immune microenvironment of pancreatic ductal adenocarcinoma","volume":"12","author":"Tang","year":"2021","journal-title":"Front Immunol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.tips.2020.10.004","article-title":"Single-cell techniques and deep learning in predicting drug response","volume":"41","author":"Wu","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41591-020-0844-1","article-title":"A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors","volume":"26","author":"Slyper","year":"2020","journal-title":"Nat Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","article-title":"Pancreatic cancer","volume":"378","author":"Vincent","year":"2011","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/diagnostics8020023","article-title":"Perspective on cancer therapeutics utilizing analysis of circulating tumor cells","volume":"8","author":"Jeong","year":"2018","journal-title":"Diagnostics"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1126\/science.1253533","article-title":"Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility","volume":"345","author":"Yu","year":"2014","journal-title":"Science"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1158\/2159-8290.CD-19-0384","article-title":"Circulating tumor cells exhibit metastatic tropism and reveal brain metastasis drivers","volume":"10","author":"Klotz","year":"2020","journal-title":"Cancer Discov"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3390\/cancers11111659","article-title":"Circulating tumor cells in pancreatic cancer: current perspectives","volume":"11","author":"Martini","year":"2019","journal-title":"Cancers"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.biotechadv.2018.03.007","article-title":"Circulating tumor cell isolation, culture, and downstream molecular analysis","volume":"36","author":"Sharma","year":"2018","journal-title":"Biotechnol Adv"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1158\/0008-5472.CAN-14-3781","article-title":"Microenvironment-modulated metastatic CD133+\/CXCR4+\/EpCAM-lung cancer-initiating cells sustain tumor dissemination and correlate with poor prognosis","volume":"75","author":"Bertolini","year":"2015","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.molonc.2014.12.001","article-title":"Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients","volume":"9","author":"Pestrin","year":"2015","journal-title":"Mol Oncol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.3390\/cancers12123774","article-title":"GAS2L1 is a potential biomarker of circulating tumor cells in pancreatic cancer","volume":"12","author":"Zhu","year":"2020","journal-title":"Cancers"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.2353\/ajpath.2010.090899","article-title":"Role of pancreatic stellate cells in pancreatic cancer metastasis","volume":"177","author":"Xu","year":"2010","journal-title":"Am J Pathol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.3390\/cancers13112763","article-title":"HGF\/c-MET inhibition as adjuvant therapy improves outcomes in an orthotopic mouse model of pancreatic cancer","volume":"13","author":"Pang","year":"2021","journal-title":"Cancers"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"688377","DOI":"10.3389\/fonc.2021.688377","article-title":"The current treatment paradigm for pancreatic ductal adenocarcinoma and barriers to therapeutic efficacy","volume":"11","author":"Principe","year":"2021","journal-title":"Front Oncol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","article-title":"Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group","volume":"25","author":"Moore","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e2200143119","DOI":"10.1073\/pnas.2200143119","article-title":"Calcium channel blockers potentiate gemcitabine chemotherapy in pancreatic cancer","volume":"119","author":"Principe","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1073\/pnas.1320753111","article-title":"Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients","volume":"111","author":"Wu","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41388-023-02590-0","article-title":"Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors","volume":"42","author":"Vorontsova","year":"2023","journal-title":"Oncogene"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41571-019-0281-6","article-title":"From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer","volume":"17","author":"Nevala-Plagemann","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc3930","article-title":"Building better monoclonal antibody-based therapeutics","volume":"15","author":"Weiner","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.trecan.2018.04.001","article-title":"Immunotherapy and prevention of pancreatic cancer","volume":"4","author":"Morrison","year":"2018","journal-title":"Trends Cancer"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","article-title":"A paradigm shift in cancer immunotherapy: from enhancement to normalization","volume":"175","author":"Sanmamed","year":"2018","journal-title":"Cells"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1158\/1078-0432.CCR-13-2234","article-title":"Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer\u2014response","volume":"19","author":"Sznol","year":"2013","journal-title":"Clin Cancer Res"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and function of the PD-L1 checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"101262","DOI":"10.1016\/j.tranon.2021.101262","article-title":"Single-cell RNA sequencing to characterize the response of pancreatic cancer to anti-PD-1 immunotherapy","volume":"15","author":"Zhou","year":"2022","journal-title":"Transl Oncol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.7554\/eLife.73796","article-title":"Multiomic characterization of pancreatic cancer-associated macrophage polarization reveals deregulated metabolic programs driven by the GM-CSF-PI3K pathway","author":"Boyer","year":"2022","journal-title":"eLife"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1136\/gutjnl-2015-309193","article-title":"Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy","volume":"65","author":"Di Caro","year":"2016","journal-title":"Gut"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.cmet.2019.02.001","article-title":"Macrophage-released pyrimidines inhibit gemcitabine therapy in pancreatic cancer","volume":"29","author":"Halbrook","year":"2019","journal-title":"Cell Metab"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cells"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"6662","DOI":"10.1073\/pnas.1121623109","article-title":"The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors","volume":"109","author":"Willingham","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tcb.2008.12.001","article-title":"Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway","volume":"19","author":"Matozaki","year":"2009","journal-title":"Trends Cell Biol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13045-019-0822-6","article-title":"Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer","volume":"12","author":"Pan","year":"2019","journal-title":"J Hematol Oncol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.addr.2015.07.007","article-title":"Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment","volume":"99","author":"Ishii","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","article-title":"Virtual microdissection identifies distinct tumor-and stroma-specific subtypes of pancreatic ductal adenocarcinoma","volume":"47","author":"Moffitt","year":"2015","journal-title":"Nat Genet"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"Ohlund","year":"2017","journal-title":"J Exp Med"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ccell.2022.04.011","article-title":"Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer","volume":"40","author":"Huang","year":"2022","journal-title":"Cancer Cell"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s41467-018-03347-0","article-title":"Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T cells to protect tumour cells","volume":"9","author":"Lakins","year":"2018","journal-title":"Nat Commun"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1038\/s41388-019-0765-y","article-title":"Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment","volume":"38","author":"Bu","year":"2019","journal-title":"Oncogene"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.3390\/cancers12113108","article-title":"Cancer-associated fibroblasts: understanding their heterogeneity","volume":"12","author":"Louault","year":"2020","journal-title":"Cancers"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","article-title":"Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy","volume":"12","author":"Liu","year":"2019","journal-title":"J Hematol Oncol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.jcmgh.2022.02.016","article-title":"Extrinsic KRAS signaling shapes the pancreatic microenvironment through fibroblast reprogramming","volume":"13","author":"Velez-Delgado","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1158\/0008-5472.CAN-18-0634","article-title":"Inverse correlation of STAT3 and MEK signaling mediates resistance to RAS pathway inhibition in pancreatic cancer","volume":"78","author":"Nagathihalli","year":"2018","journal-title":"Cancer Res"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1053\/j.gastro.2022.07.076","article-title":"Combined MEK and STAT3 inhibition uncovers stromal plasticity by enriching for cancer-associated fibroblasts with mesenchymal stem cell-like features to overcome immunotherapy resistance in pancreatic cancer","volume":"163","author":"Datta","year":"2022","journal-title":"Gastroenterology"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1158\/2326-6066.CIR-21-1088","article-title":"Extracellular galectin 4 drives immune evasion and promotes T-cell apoptosis in pancreatic cancer","volume":"11","author":"Lidstrom","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/cells7110208","article-title":"Hedgehog signaling in cancer: a prospective therapeutic target for eradicating cancer stem cells","volume":"7","author":"Sari","year":"2018","journal-title":"Cells"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1158\/1078-0432.CCR-14-1269","article-title":"Pilot clinical trial of Hedgehog pathway inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinoma","volume":"20","author":"Kim","year":"2014","journal-title":"Clin Cancer Res"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.1200\/JCO.2015.62.8719","article-title":"Randomized phase Ib\/II study of gemcitabine plus placebo or vismodegib, a Hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer","volume":"33","author":"Catenacci","year":"2015","journal-title":"J Clin Oncol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1158\/1078-0432.CCR-20-3715","article-title":"Inhibition of Hedgehog signaling alters fibroblast composition in pancreatic cancer","volume":"27","author":"Steele","year":"2021","journal-title":"Clin Cancer Res"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/01.sla.0000201480.65519.b8","article-title":"A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma","volume":"243","author":"Chen","year":"2006","journal-title":"Ann Surg"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1007\/s00330-019-06189-6","article-title":"Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy","volume":"29","author":"Minami","year":"2019","journal-title":"Eur Radiol"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41419-020-02787-1","article-title":"High-dimensional single-cell analysis delineates radiofrequency ablation induced immune microenvironmental remodeling in pancreatic cancer","volume":"11","author":"Fei","year":"2020","journal-title":"Cell Death Dis"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4254\/wjh.v3.i1.8","article-title":"Radiofrequency ablation of liver tumors: actual limitations and potential solutions in the future","volume":"3","author":"Kunzli","year":"2011","journal-title":"World J Hepatol"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"108266","DOI":"10.1016\/j.bioelechem.2022.108266","article-title":"Single-cell analysis reveals nanosecond pulsed electric field ablation induced myeloid cells remodeling in pancreatic cancer","volume":"148","author":"Zhao","year":"2022","journal-title":"Bioelectrochemistry"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41568-019-0213-x","article-title":"Controversies around epithelial-mesenchymal plasticity in cancer metastasis","volume":"19","author":"Williams","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.devcel.2019.04.012","article-title":"Metastasis organotropism: redefining the congenial soil","volume":"49","author":"Gao","year":"2019","journal-title":"Dev Cell"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","article-title":"Guidelines and definitions for research on epithelial-mesenchymal transition","volume":"21","author":"Yang","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bbcan.2018.07.001","article-title":"Hybrid epithelial\/mesenchymal phenotype (s): the \u2018fittest\u2019 for metastasis?","volume":"1870","author":"Jolly","year":"2018","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"108990","DOI":"10.1016\/j.celrep.2021.108990","article-title":"Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer","volume":"35","author":"Carstens","year":"2021","journal-title":"Cell Rep"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.1007\/s00520-020-05346-8","article-title":"Incidence and frequency of cancer cachexia during chemotherapy for advanced pancreatic ductal adenocarcinoma","volume":"28","author":"Mitsunaga","year":"2020","journal-title":"Support Care Cancer"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s11605-008-0505-z","article-title":"Cachexia worsens prognosis in patients with resectable pancreatic cancer","volume":"12","author":"Bachmann","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41416-021-01301-4","article-title":"Pancreatic cancer cachexia: three dimensions of a complex syndrome","volume":"124","author":"Kordes","year":"2021","journal-title":"Br J Cancer"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41586-019-1831-x","article-title":"Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis","volume":"576","author":"Ramirez","year":"2019","journal-title":"Nature"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1053\/j.gastro.2022.06.058","article-title":"Acetyl-coenzyme a synthetase 2 potentiates macropinocytosis and muscle wasting through metabolic reprogramming in pancreatic cancer","volume":"163","author":"Zhou","year":"2022","journal-title":"Gastroenterology"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature19084","article-title":"Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion","volume":"536","author":"Sousa","year":"2016","journal-title":"Nature"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cells"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"216040","DOI":"10.1016\/j.canlet.2022.216040","article-title":"Pancreatic stellate cells exploit Wnt\/beta-catenin\/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth","volume":"555","author":"Liu","year":"2023","journal-title":"Cancer Lett"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0899-9007(00)00413-5","article-title":"Central nervous system mechanisms contributing to the cachexia-anorexia syndrome","volume":"16","author":"Plata-Salaman","year":"2000","journal-title":"Nutrition"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.physbeh.2010.03.011","article-title":"Hypothalamic mechanisms in cachexia","volume":"100","author":"Grossberg","year":"2010","journal-title":"Physiol Behav"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jphs.2019.04.005","article-title":"A novel strategy for treatment of cancer cachexia targeting xanthine oxidase in the brain","volume":"140","author":"Uzu","year":"2019","journal-title":"J Pharmacol Sci"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"101441","DOI":"10.1016\/j.molmet.2022.101441","article-title":"Critical changes in hypothalamic gene networks in response to pancreatic cancer as found by single-cell RNA sequencing","volume":"58","author":"Huisman","year":"2022","journal-title":"Mol Metab"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13046-021-01955-1","article-title":"What are the applications of single-cell RNA sequencing in cancer research: a systematic review","volume":"40","author":"Li","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-021-01105-2","article-title":"Applications of single-cell sequencing in cancer research: progress and perspectives","volume":"14","author":"Lei","year":"2021","journal-title":"J Hematol Oncol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1213136\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T09:47:53Z","timestamp":1693475273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1213136\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":102,"alternative-id":["10.3389\/fmed.2023.1213136"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1213136","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"article-number":"1213136"}}